Latest news with #Chemours
Yahoo
11-07-2025
- Business
- Yahoo
Chemours (CC) Surges 9.7% as EPA Withdraws Ban on Chrysotile Asbestos
The Chemours Company (NYSE:CC) is one of . The Chemours Company (NYSE:CC) saw its share prices increase by 9.74 percent on Tuesday to end at $13.63 apiece following the US Environmental Protection Agency's (EPA) decision to withdraw a plan to ban chrysotile asbestos. Chrysotile asbestos, also known as white asbestos, is commonly used in buildings and industrial applications. It is currently banned in over 50 countries for its connection to lung cancer and mesothelioma. However, it is imported for use in the US for roofing materials, textiles, and cement, and is also used in gaskets, clutches, brake pads, and other automotive parts, as well as in chlorine manufacturing. A technician performing quality checks on a range of specialty chemicals. The EPA adopted a ban in 2024 on the use, manufacture, and import of chrysotile asbestos. The Chemours Company (NYSE:CC), for its part, uses the mineral in operations involving titanium dioxide. While we acknowledge the potential of CC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
The Independent
24-06-2025
- Business
- The Independent
Wisconsin Supreme Court delivers win for environmentalists in fight over ‘forever chemicals'
The Wisconsin Supreme Court delivered a victory for environmentalists on Tuesday in the fight over 'forever chemicals' known as PFAS. The liberal-controlled court ruled that state regulators can force landowners to clean up emerging pollutants such as PFAS before they are officially designated as hazardous substances. The 5-2 ruling is a defeat for the state's powerful group representing businesses and manufacturers, which had argued the state couldn't enforce regulations on substances before they were officially designated as hazardous. It is the latest development in a yearslong battle in Wisconsin and nationally involving regulators, environmentalists, politicians and businesses over how to deal with PFAS contamination. The PFAS problem Cities large and small across Wisconsin, from Madison to Marinette and La Crosse to Wausau, are grappling with PFAS contamination. The U.S. Geological Survey has estimated that at least 45% of the nation's tap water is contaminated with PFAS. PFAS, or perfluoroalkyl and polyfluoroalkyl substances, are a group of chemicals that have been around for decades and have now spread into the nation's air, water and soil. They were manufactured by companies such as 3M, Chemours and others because they were incredibly useful. They helped eggs slide across nonstick frying pans, ensured that firefighting foam suffocates flames and helped clothes withstand the rain and keep people dry. The chemicals resist breaking down, however, which means they stay around in the environment and have a hard time breaking down in the body. There is a wide range of health harms now associated with exposure to certain PFAS, including low birth weight, cancer and liver disease. Democratic Gov. Tony Evers and Republican legislators have been at odds over how to address the problem for years, with both sides blaming the other for not earmarking more money for clean up efforts. The Wisconsin case The Wisconsin Supreme Court ruled in a case brought by the state's largest business group, Wisconsin Manufacturers & Commerce, which sued the DNR in 2021 on behalf of Leather Rich, a dry cleaning business in Oconomowoc. Leather Rich became aware of PFAS contamination in 2018 and was working on cleaning it up when the DNR posted a message online in 2019 saying it now considered PFAS chemicals a hazardous substance. The agency ordered the dry cleaner to test its groundwater for PFAS but didn't tell the business which compounds it needed to test for or what levels would be considered dangerous. They argued the DNR can't force businesses to test and clean up contamination from emerging pollutants like PFAS without first designating them as hazardous substances. That process can take years and requires approval from the Legislature. A Waukesha County judge and the state appeals court sided with Leather Rich. The DNR appealed, arguing that it could unilaterally force testing because state law gives the agency broad authority to protect the environment. It also argued that the lower court's ruling would neuter the state's 'spills law,' which was designed to confront pollution. That law, enacted about 50 years ago, requires anyone who causes, possesses or controls a hazardous substance that's been released into the environment to clean it up. Fight over PFAS regulation Since the lawsuit was filed, additional state and federal regulations of PFAS have been put in place. Federal regulators placed the first-ever national standards on PFAS in drinking water last year, but the Trump administration said in May that it planned to weaken those limits. The state has imposed less restrictive limits on PFAS in surface and drinking water, defined as piped water delivered through public systems and noncommunity systems that serve places such as factories, schools and hotels. But it has not implemented PFAS standards for groundwater, the source of drinking water for about two-thirds of Wisconsin residents. The agency stopped efforts to draft them in 2023 after determining that compliance would be too expensive.
Associated Press
24-06-2025
- Politics
- Associated Press
Wisconsin Supreme Court delivers win for environmentalists in fight over ‘forever chemicals'
MADISON, Wis. (AP) — The Wisconsin Supreme Court delivered a victory for environmentalists on Tuesday in the fight over 'forever chemicals' known as PFAS. The liberal-controlled court ruled that state regulators can force landowners to clean up emerging pollutants such as PFAS before they are officially designated as hazardous substances. The 5-2 ruling is a defeat for the state's powerful group representing businesses and manufacturers, which had argued the state couldn't enforce regulations on substances before they were officially designated as hazardous. It is the latest development in a yearslong battle in Wisconsin and nationally involving regulators, environmentalists, politicians and businesses over how to deal with PFAS contamination. The PFAS problem Cities large and small across Wisconsin, from Madison to Marinette and La Crosse to Wausau, are grappling with PFAS contamination. The U.S. Geological Survey has estimated that at least 45% of the nation's tap water is contaminated with PFAS. PFAS, or perfluoroalkyl and polyfluoroalkyl substances, are a group of chemicals that have been around for decades and have now spread into the nation's air, water and soil. They were manufactured by companies such as 3M, Chemours and others because they were incredibly useful. They helped eggs slide across nonstick frying pans, ensured that firefighting foam suffocates flames and helped clothes withstand the rain and keep people dry. The chemicals resist breaking down, however, which means they stay around in the environment and have a hard time breaking down in the body. There is a wide range of health harms now associated with exposure to certain PFAS, including low birth weight, cancer and liver disease. Democratic Gov. Tony Evers and Republican legislators have been at odds over how to address the problem for years, with both sides blaming the other for not earmarking more money for clean up efforts. The Wisconsin case The Wisconsin Supreme Court ruled in a case brought by the state's largest business group, Wisconsin Manufacturers & Commerce, which sued the DNR in 2021 on behalf of Leather Rich, a dry cleaning business in Oconomowoc. Leather Rich became aware of PFAS contamination in 2018 and was working on cleaning it up when the DNR posted a message online in 2019 saying it now considered PFAS chemicals a hazardous substance. The agency ordered the dry cleaner to test its groundwater for PFAS but didn't tell the business which compounds it needed to test for or what levels would be considered dangerous. They argued the DNR can't force businesses to test and clean up contamination from emerging pollutants like PFAS without first designating them as hazardous substances. That process can take years and requires approval from the Legislature. A Waukesha County judge and the state appeals court sided with Leather Rich. The DNR appealed, arguing that it could unilaterally force testing because state law gives the agency broad authority to protect the environment. It also argued that the lower court's ruling would neuter the state's 'spills law,' which was designed to confront pollution. That law, enacted about 50 years ago, requires anyone who causes, possesses or controls a hazardous substance that's been released into the environment to clean it up. Fight over PFAS regulation Since the lawsuit was filed, additional state and federal regulations of PFAS have been put in place. Federal regulators placed the first-ever national standards on PFAS in drinking water last year, but the Trump administration said in May that it planned to weaken those limits. The state has imposed less restrictive limits on PFAS in surface and drinking water, defined as piped water delivered through public systems and noncommunity systems that serve places such as factories, schools and hotels. But it has not implemented PFAS standards for groundwater, the source of drinking water for about two-thirds of Wisconsin residents. The agency stopped efforts to draft them in 2023 after determining that compliance would be too expensive.
CNBC
18-06-2025
- Business
- CNBC
Stocks making the biggest moves premarket: Sunrun, Korn Ferry, Oracle, Circle and more
Check out the companies making headlines in premarket trading. Sunrun — Shares fell nearly 2% following a downgrade to sector perform from outperform by RBC Capital Markets. The stock on Tuesday recorded its biggest one-day loss in its history amid a sell-off in solar names. CERo Therapeutics Holdings — Stock in the immunotherapy company pulled back about 28%. On Tuesday, the U.S. Food and Drug Administration gave the company's acute myeloid leukemia drug CER-1236 an orphan drug designation . Shares rose more than 188% on that news. Chemours — The chemical stock dropped about 1% after an updated second-quarter forecast showed weakness in a key profit metric. Chemours said it expects consolidated adjusted EBITDA — or earnings before interest, taxes, depreciation and amortization — of $215 million to $225 million for the period. Wall Street expectations called for $236 million, according to FactSet. Regencell Bioscience — Shares dropped 13% after an eyewatering move higher this week . The Hong Kong-based developer of traditional Chinese herbal treatments has said it can treat childhood ADHD and autism. Regencell jumped 30% on Tuesday, and soared 283% Monday, following a 38-for-1 stock split. It's gained more than 59,000% this year. Oracle — The software company gained more than 1% after Guggenheim raised its price target on the stock to the highest on the Street. Analyst John DiFucci said Oracle is "on the precipice of a narrative shift that has been decades of technology innovation in the making." Zoetis — Shares of the animal health company slipped 1% following a downgrade at Stifel to hold from buy. The firm said it expects Zoetis' revenue growth to decelerate further amid increasing competition. Korn Ferry — Shares of the consulting firm gained about 10% after fourth-quarter results surpassed analyst estimates on the top and bottom line. Korn Ferry earned $1.32 per share, excluding items, on revenue of $712 million. Analysts polled by FactSet expected a profit of $1.26 per share and revenue of $689.9 million. Circle Internet Group — Stock in the company behind stablecoin USDC advanced 3%, after the U.S. Senate passed the GENIUS bill . The legislation is the first of its kind and establishes federal guidelines for digital dollars that are pegged to the greenback. — CNBC's Sarah Min, Michelle Fox, Alex Harring, Fred Imbert and Jesse Pound contributed reporting.
Associated Press
18-06-2025
- Business
- Associated Press
The Chemours Company Provides Update on Second Quarter 2025 Outlook
WILMINGTON, Del.--(BUSINESS WIRE)--Jun 18, 2025-- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM), today provided an update on its second quarter 2025 outlook. For the second quarter of 2025, due to better-than-expected performance, TSS now anticipates a sequential increase in Net Sales of approximately 25% driven by strong demand for Opteon™ Refrigerants, in connection with the stationary transition to low global warming potential refrigerants under the U.S. AIM Act. Consistent with this increased demand, TSS also projects a sequential increase in Adjusted EBITDA of nearly 40% for the quarter. APM's Adjusted EBITDA for the second quarter is also anticipated to increase nearly 25% sequentially due to stronger overall cost performance, while Net Sales are anticipated to be within original expectations of low teens sequential growth. For TT, the Company anticipates overall Net Sales for the second quarter to be in line with the segment's high single-digit growth expectations. However, second quarter Adjusted EBITDA for TT is now projected to decline approximately 15% sequentially, due to operational disruptions at its U.S. sites. These disruptions were primarily caused by a rail line service interruption impacting feedstock mix and other limited operational issues. In order to fulfill customer orders due to the rail line disruption, the Company elected to consume higher-cost ore feedstock, which resulted in incremental costs of approximately $15 million in the second quarter. The costs associated with other one-time operational disruptions are expected to be approximately $10 million for the quarter. As a part of the Company's strategic focus to resolve legacy litigation, under the Strengthening the Long Term pillar, the Company now anticipates overall corporate costs for the second quarter to be slightly higher-than-expected in connection with the ongoing New Jersey trial. Overall, consolidated Net Sales for the second quarter are expected to be at the high end of the original range, now anticipating a sequential mid-teens increase. Consolidated Adjusted EBITDA is now projected to range between $215 and $225 million, with consolidated Free Cash Flow projected to remain positive in the second quarter. The Company will provide a more comprehensive update in connection with its second quarter earnings process, the date of which will be communicated after the close of the second quarter. About The Chemours Company The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 6,000 employees and 28 manufacturing sites and serves approximately 2,500 customers in approximately 110 countries. For more information, visit or follow us on LinkedIn. Non-GAAP Financial Measures We prepare our financial statements in accordance with Generally Accepted Accounting Principles (GAAP). Within this press release, we make reference to Adjusted EBITDA and Free Cash Flow, which are non-GAAP financial measures. The Company includes these non-GAAP financial measures because management believes they are useful to investors in that they provide for greater transparency with respect to supplemental information used by management in its financial and operational decision making. Management uses Adjusted EBITDA, which is adjusted for (i) certain non-cash items, (ii) certain items we believe are not indicative of ongoing operating performance or (iii) certain nonrecurring, unusual or infrequent items to evaluate the Company's performance in order to have comparable financial results to analyze changes in our underlying business from period to period. Additionally, Free Cash Flow is utilized as liquidity measures to assess the cash generation of our businesses and on-going liquidity position. Accordingly, the Company believes the presentation of these non-GAAP financial measures, when used in conjunction with GAAP financial measures, is a useful financial analysis tool that can assist investors in assessing the Company's operating performance and underlying prospects. This analysis should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. This analysis, as well as the other information in this press release, should be read in conjunction with the Company's financial statements and footnotes contained in the documents that the Company files with the U.S. Securities and Exchange Commission. The non-GAAP financial measures used by the Company in this press release may be different from the methods used by other companies. The Company does not provide a reconciliation of these forward-looking non-GAAP financial measures to the most directly comparable GAAP reported financial measures on a forward-looking basis because it is unable to predict with reasonable certainty the ultimate outcome of unusual gains and losses, potential future asset impairments and pending litigation without unreasonable effort. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period. Forward-Looking Statements This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words 'believe,' 'expect,' 'will,' 'anticipate,' 'plan,' 'estimate,' 'target,' 'project' and similar expressions, among others, generally identify 'forward-looking statements,' which speak only as of the date such statements were made. These forward-looking statements may address, among other things, guidance and expectations of the Company and segment performance for the second quarter of 2025, which is subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions, geopolitical conditions and global health events, and changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our products or increase raw material, energy or other input costs, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Annual Report on Form 10-K for the year ended December 31, 2024 and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law. View source version on CONTACT: INVESTORS Brandon Ontjes VP, Head of Strategy & Investor Relations +1.302.773.3300 [email protected] MEDIA Cassie Olszewski Media Relations & Reputation Leader +1.302.219.7140 [email protected] KEYWORD: UNITED STATES NORTH AMERICA DELAWARE INDUSTRY KEYWORD: SEMICONDUCTOR CHEMICALS/PLASTICS OTHER ENERGY TECHNOLOGY MANUFACTURING ENERGY OTHER MANUFACTURING SOURCE: The Chemours Company Copyright Business Wire 2025. PUB: 06/18/2025 06:45 AM/DISC: 06/18/2025 06:44 AM
